Research Pit

[Mr. Zen]

WTF are they for real??

Medical Marijuana, Inc. and CanChew Biotechnologies Have Officially Started
Market Trial Sign-Ups for CBD Chewing Gum

SAN DIEGO, Oct. 16, 2012 /PRNewswire via COMTEX/ -- Medical Marijuana, Inc.
(MJNA), a leading hemp industry innovator and its CanChew Biotechnologies
portfolio company have commenced market trial sign ups for the CanChew CBD
chewing gum product line. The free market trial offer is open to patients
suffering from pain from MS Muscular Spasticity, Cancer, Neuropathic Conditions,
Psychological/Mood Disorders and Arthritis. The trial will be managed by CanChew
Directors: Dr. George Anastassov, Dr. Philip A. Van Damme, and Production
Specialist Lekhram Changoer. The sign-up period is underway and will last until
November 15th or until all of the participant slots are filled.

Since announcing the trial on October 1, the company has received terrific
feedback from many qualifying patient participants and looks forward to a strong
program.

For more information about the trial qualifications and registration, please
visit http://canchewbiotech.com/ and click on the "Join Our Free Trial" link.
Prospective patients are now able to log into a dedicated website and answer
questions on a health history survey to determine their eligibility. Patients who
qualify for the trial will receive a minimum one-month supply of the CBD chewing
gum, which contains approximately 8-10 milligrams of CBD per piece and will be
blister packed in packages of 8 and 32 pieces. Patients will provide specific
feedback to the Company regarding usage and experience. While the company has
been underway with clinical development for many months, it expects to launch
human Clinical trials for this product and other CBD containing products by the
end of 2013. CanChew Biotechnologies expects to launch over-the-counter retail
sales of the product in early 2013.